Efficacy and safety of switching from baricitinib to ritlecitinib in severe alopecia areataClinical and Experimental DermatologyDecember 21, 202410.1093/ced/llae548Cited by 8SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis